Loading...
  • hematologic malignancies
  • For hematologic malignancies incurable with conventional dose chemotherapy, such as low-grade lymphomas, multiple myeloma, myelodysplastic syndromes, and poor risk acute leukemias, allogeneic BMT usually becomes the treatment of choice at the time survival duration is felt to be relatively short. (oncologynurseadvisor.com)
  • peripheral blood
  • The optimal numbers for each cell type in the bone marrow or peripheral blood progenitor cell allograft are not known. (cancernetwork.com)
  • While peripheral blood grafts may seem to be logistically easier to collect, as a bone marrow harvest requires multiple needle puncture in the pelvic bone in an operating room under anesthesia, it requires five days of growth factor injections and 6-12 hours on an apheresis machine. (oncologynurseadvisor.com)
  • acute
  • For those diseases curable with conventional dose therapy, such as aggressive lymphomas and many acute leukemias, allogeneic BMT is reserved for, and is often the treatment of choice, at initial relapse. (oncologynurseadvisor.com)
  • age range, 19 to 53 years) had had allogeneic BMT from HLA-matched family or nonrelated donors for treatment of chronic myelogenous leukemia (n=3), acute myelogenous leukemia (n=1), and acute lymphoblastic leukemia (n=1). (ahajournals.org)
  • Relapse of acute leukemia after marrow transplantation. (springer.com)
  • A 16 year old man underwent an allogeneic bone marrow transplantation (BMT) from an HLA identical sibling donor for acute lymphoblastic leukaemia in 1984. (bmj.com)
  • en] A 37-year-old man with acute myeloblastic leukemia in first remission developed ulcerative colitis and bronchiolitis obliterans organizing pneumonia (BOOP) 7 months after bone marrow transplantation (BMT) from an HLA-matched brother who suffered from severe Crohn's disease. (ac.be)
  • A woman with T acute lymphoblastic leukaemia (T-ALL) received an allogeneic BMT from a donor with the β-thalassaemic trait. (hku.hk)
  • Thrombocytopenia
  • Seven years after BMT, thrombocytopenia developed and marrow examination confirmed t-MDS, with a characteristic karyotype 46.XX,inv(3)(q21:q26), del(5)(q13),add(17)(p11). (hku.hk)
  • rats
  • Allogeneic BMSCs mainly appeared not at the parenchymatous organs but at the subepidermal connective tissue and adipose tissue in healthy rats. (hindawi.com)